Pharmaceuticals

Lonza reported continued positive momentum in its core healthcare businesses in the first six months of 2019. This has driven...

Merck, a science and technology company, and the Broad Institute of MIT and Harvard (Boston, Massachusetts) announced an agreement to...

Engineers and designers are always looking for solutions to make their and our life easier. Especially in our times, which...

The new conical tube format of 25 mL, developed by the inventor of the “Eppi” tube, will advance the world...

Lonza announced the start of expansion to its bioconjugation facility in Visp, Switzerland together with the successful commercial approval of...

Merck, a science and technology company, announced that its proposed transaction with Intermolecular, was approved by the stockholders of Intermolecular...

Filter solutions provide are an important cornerstone of hygienic production environments, as required in the pharmaceutical and other process industries....

Merck, a science and technology company, today successfully placed bonds amounting to € 2.0 billion. The placement is a component...

Following the news that the FDA has approved Dupixent for the treatment of chronic rhinosinusitis with nasal polyposis; “Dupixent is...

Merck, a science and technology company, announced that its transaction with Versum Materials was approved at a special meeting of...